NASDAQ:HCAT Health Catalyst (HCAT) Stock Price, News & Analysis → [Urgent!] Generational Wealth Gameplan (From Crypto 101 Media) (Ad) Free HCAT Stock Alerts $5.62 +0.09 (+1.63%) (As of 04/17/2024 ET) Add Compare Share Share Today's Range$5.52▼$5.7350-Day Range$5.53▼$10.2652-Week Range$5.51▼$14.37Volume585,279 shsAverage Volume616,548 shsMarket Capitalization$329.40 millionP/E RatioN/ADividend YieldN/APrice Target$12.10 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Get Health Catalyst alerts: Email Address Health Catalyst MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.64 Rating ScoreUpside/Downside115.1% Upside$12.10 Price TargetShort InterestHealthy2.60% of Shares Sold ShortDividend StrengthN/ASustainability-0.91Upright™ Environmental ScoreNews Sentiment0.61Based on 9 Articles This WeekInsider TradingSelling Shares$12,251 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($0.47) to ($0.28) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.86 out of 5 starsMedical Sector30th out of 914 stocksComputer Programming, Data Processing, & Other Computer Related Industry3rd out of 59 stocks 4.3 Analyst's Opinion Consensus RatingHealth Catalyst has received a consensus rating of Moderate Buy. The company's average rating score is 2.64, and is based on 7 buy ratings, 4 hold ratings, and no sell ratings.Amount of Analyst CoverageHealth Catalyst has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 5.0 Short Interest Percentage of Shares Shorted2.60% of the outstanding shares of Health Catalyst have been sold short.Short Interest Ratio / Days to CoverHealth Catalyst has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Health Catalyst has recently decreased by 16.48%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldHealth Catalyst does not currently pay a dividend.Dividend GrowthHealth Catalyst does not have a long track record of dividend growth. Previous Next 3.8 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreHealth Catalyst has received a 48.83% net impact score from Upright. Health Catalyst seems to create the most significant positive value in categories "Taxes", "Creating knowledge", and "Physical diseases". The positive contribution in the "Creating knowledge" impact category is mostly driven by its "Health data collection software", "Data analytics services", and "Drug discovery software" products. See details.Environmental SustainabilityThe Environmental Impact score for Health Catalyst is -0.91. Previous Next 3.1 News and Social Media Coverage News SentimentHealth Catalyst has a news sentiment score of 0.61. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.40 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 9 news articles for Health Catalyst this week, compared to 3 articles on an average week.Search InterestOnly 5 people have searched for HCAT on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows8 people have added Health Catalyst to their MarketBeat watchlist in the last 30 days. This is an increase of 60% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Health Catalyst insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $12,251.00 in company stock.Percentage Held by InsidersOnly 2.70% of the stock of Health Catalyst is held by insiders.Percentage Held by Institutions85.00% of the stock of Health Catalyst is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Health Catalyst are expected to grow in the coming year, from ($0.47) to ($0.28) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Health Catalyst is -2.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Health Catalyst is -2.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHealth Catalyst has a P/B Ratio of 0.88. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 Media[Urgent!] Generational Wealth GameplanA brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide About Health Catalyst Stock (NASDAQ:HCAT)Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.Read More HCAT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HCAT Stock News HeadlinesApril 16, 2024 | americanbankingnews.comComparing WELL Health Technologies (OTCMKTS:WLYYF) & Health Catalyst (NASDAQ:HCAT)April 14, 2024 | americanbankingnews.comHealth Catalyst, Inc. (NASDAQ:HCAT) Given Average Recommendation of "Moderate Buy" by AnalystsApril 17, 2024 | Crypto 101 Media (Ad)[Urgent!] Generational Wealth GameplanA brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.April 13, 2024 | seekingalpha.comOscar Health: Strong Industry Catalyst With Margin Expansion PotentialApril 12, 2024 | americanbankingnews.comHealth Catalyst (NASDAQ:HCAT) Stock Rating Reaffirmed by KeyCorpApril 11, 2024 | americanbankingnews.comHealth Catalyst (NASDAQ:HCAT) Given "Overweight" Rating at Cantor FitzgeraldMarch 17, 2024 | finance.yahoo.comHCAT Dec 2024 10.000 putMarch 17, 2024 | finance.yahoo.comHCAT Apr 2024 7.500 putApril 17, 2024 | Crypto 101 Media (Ad)[Urgent!] Generational Wealth GameplanA brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.March 16, 2024 | finance.yahoo.comHCAT Apr 2024 10.000 callMarch 16, 2024 | finance.yahoo.comHCAT Dec 2024 17.500 callMarch 11, 2024 | msn.comScientists design bifunctional catalyst to address environmental pollution problemsMarch 9, 2024 | seekingalpha.comHealth Catalyst: Achieving FY28 Long-Term Guidance Is PossibleMarch 5, 2024 | finance.yahoo.comDaniel Burton Bought 3.2% More Shares In Health CatalystMarch 4, 2024 | finance.yahoo.comHealth Catalyst to Participate in Upcoming Investor ConferencesFebruary 28, 2024 | msn.comHealth Catalyst rises following disclosure of CEO share purchaseFebruary 27, 2024 | prnewswire.comHealth Catalyst Names UnityPoint Health Winner of the 2024 Flywheel AwardFebruary 27, 2024 | finance.yahoo.comThe 2024 Healthcare Analytics Summit (HAS) Kicks Off TodayFebruary 26, 2024 | markets.businessinsider.comMaintaining Buy Rating on Health Catalyst: Strong Sales Pipeline and Margin Outlook Offset Slower Growth ForecastFebruary 24, 2024 | ca.finance.yahoo.comBank of Canada to cut interest rates in half by end of next year: DesjardinsFebruary 24, 2024 | finance.yahoo.comHealth Catalyst Full Year 2023 Earnings: EPS Misses ExpectationsFebruary 23, 2024 | markets.businessinsider.comOptimistic Outlook: Health Catalyst’s Growth and Profitability Potential Affirm Buy RatingFebruary 23, 2024 | markets.businessinsider.comAnalyst Scoreboard: 5 Ratings For Health CatalystFebruary 23, 2024 | finance.yahoo.comHealth Catalyst, Inc. (NASDAQ:HCAT) Q4 2023 Earnings Call TranscriptFebruary 23, 2024 | finance.yahoo.comQ4 2023 Health Catalyst Inc Earnings CallFebruary 22, 2024 | msn.comHealth Catalyst GAAP EPS of -$0.53 misses by $0.18, revenue of $75.08M beats by $1.49MFebruary 22, 2024 | finance.yahoo.comHealth Catalyst (NASDAQ:HCAT) Exceeds Q4 Expectations But Full-Year Guidance UnderwhelmsSee More Headlines Receive HCAT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Health Catalyst and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/22/2024Today4/17/2024Next Earnings (Estimated)5/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Computer programming, data processing, & other computer related Sub-IndustryN/A Current SymbolNASDAQ:HCAT CUSIPN/A CIK1636422 Webwww.healthcatalyst.com Phone(801) 708-6800FaxN/AEmployees1,300Year FoundedN/APrice Target and Rating Average Stock Price Target$12.10 High Stock Price Target$16.00 Low Stock Price Target$8.00 Potential Upside/Downside+111.5%Consensus RatingModerate Buy Rating Score (0-4)2.64 Research Coverage11 Analysts Profitability EPS (Most Recent Fiscal Year)($2.10) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-118,150,000.00 Net Margins-39.92% Pretax Margin-39.80% Return on Equity-12.19% Return on Assets-6.51% Debt Debt-to-Equity Ratio0.62 Current Ratio4.42 Quick Ratio4.42 Sales & Book Value Annual Sales$295.94 million Price / Sales1.13 Cash FlowN/A Price / Cash FlowN/A Book Value$6.38 per share Price / Book0.90Miscellaneous Outstanding Shares58,560,000Free Float56,982,000Market Cap$334.96 million OptionableOptionable Beta1.29 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. Daniel D. Burton (Age 48)CEO & Director Comp: $158.9kMr. Daniel H. Orenstein (Age 54)Senior Advisor Comp: $356.56kMr. Kevin Freeman (Age 51)Chief Commercial Officer Comp: $405.9kMr. Jason Alger (Age 40)CFO & Chief Accounting Officer Mr. Daniel LeSueurChief Operating OfficerMr. Dave RossChief Technology OfficerMr. Adam BrownSenior Vice President of Investor Relations and Financial Planning & AnalysisMr. Benjamin LandryGeneral Counsel & Secretary of the BoardMs. Tarah Neujahr BryanChief Marketing & Communications OfficerMr. Kyle J. SalyersChief Strategy Officer & Senior VP of Corporate DevelopmentMore ExecutivesKey CompetitorsSOPHiA GENETICSNASDAQ:SOPHEnanta PharmaceuticalsNASDAQ:ENTALyra TherapeuticsNASDAQ:LYRAInvivydNASDAQ:IVVDAurora CannabisNASDAQ:ACBView All CompetitorsInsiders & InstitutionsLinda LlewelynSold 2,005 sharesTotal: $12,250.55 ($6.11/share)Nepsis Inc.Bought 65,462 shares on 4/12/2024Ownership: 1.976%Los Angeles Capital Management LLCBought 45,115 shares on 4/5/2024Ownership: 0.097%Vanguard Group Inc.Sold 933,735 shares on 3/11/2024Ownership: 9.406%Goldman Sachs Group Inc.Bought 335,823 shares on 3/1/2024Ownership: 2.084%View All Insider TransactionsView All Institutional Transactions HCAT Stock Analysis - Frequently Asked Questions Should I buy or sell Health Catalyst stock right now? 11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Health Catalyst in the last twelve months. There are currently 4 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" HCAT shares. View HCAT analyst ratings or view top-rated stocks. What is Health Catalyst's stock price target for 2024? 11 brokerages have issued 1 year price targets for Health Catalyst's stock. Their HCAT share price targets range from $8.00 to $16.00. On average, they anticipate the company's stock price to reach $12.10 in the next year. This suggests a possible upside of 115.1% from the stock's current price. View analysts price targets for HCAT or view top-rated stocks among Wall Street analysts. How have HCAT shares performed in 2024? Health Catalyst's stock was trading at $9.26 on January 1st, 2024. Since then, HCAT shares have decreased by 39.3% and is now trading at $5.6250. View the best growth stocks for 2024 here. Are investors shorting Health Catalyst? Health Catalyst saw a decrease in short interest in the month of March. As of March 31st, there was short interest totaling 1,520,000 shares, a decrease of 16.5% from the March 15th total of 1,820,000 shares. Based on an average daily volume of 617,600 shares, the short-interest ratio is presently 2.5 days. View Health Catalyst's Short Interest. When is Health Catalyst's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024. View our HCAT earnings forecast. How were Health Catalyst's earnings last quarter? Health Catalyst, Inc. (NASDAQ:HCAT) released its quarterly earnings data on Thursday, February, 22nd. The company reported ($0.21) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.06. The firm had revenue of $75.08 million for the quarter, compared to analysts' expectations of $73.67 million. Health Catalyst had a negative trailing twelve-month return on equity of 12.19% and a negative net margin of 39.92%. What ETFs hold Health Catalyst's stock? ETFs with the largest weight of Health Catalyst (NASDAQ:HCAT) stock in their portfolio include Fidelity Digital Health ETF (FDHT), ROBO Global Healthcare Technology and Innovation ETF (HTEC) and First Trust Nasdaq Lux Digital Health Solutions ETF (EKG).iShares U.S. Healthcare Providers ETF (IHF). What guidance has Health Catalyst issued on next quarter's earnings? Health Catalyst issued an update on its first quarter 2024 earnings guidance on Thursday, February, 22nd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $72.5 million-$76.5 million, compared to the consensus revenue estimate of $79.0 million. What is Dan Burton's approval rating as Health Catalyst's CEO? 501 employees have rated Health Catalyst Chief Executive Officer Dan Burton on Glassdoor.com. Dan Burton has an approval rating of 99% among the company's employees. This puts Dan Burton in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 83.0% of employees surveyed would recommend working at Health Catalyst to a friend. What other stocks do shareholders of Health Catalyst own? Based on aggregate information from My MarketBeat watchlists, some companies that other Health Catalyst investors own include NVIDIA (NVDA), Salesforce (CRM), Alteryx (AYX), Walt Disney (DIS), DocuSign (DOCU), Block (SQ), Slack Technologies (WORK), ServiceNow (NOW), Marvell Technology (MRVL) and PayPal (PYPL). When did Health Catalyst IPO? Health Catalyst (HCAT) raised $129 million in an initial public offering (IPO) on Thursday, July 25th 2019. The company issued 6,000,000 shares at $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan and William Blair acted as the underwriters for the IPO and Piper Jaffray, Evercore ISI, SVB Leerink and SunTrust Robinson Humphrey were co-managers. Who are Health Catalyst's major shareholders? Health Catalyst's stock is owned by a number of retail and institutional investors. Top institutional investors include Nepsis Inc. (1.98%) and Los Angeles Capital Management LLC (0.10%). Insiders that own company stock include Anita Pramoda, Benjamin Landry, Bryan Richard Hinton, Bryan Truman Hunt, Daniel D Burton, Daniel H Orenstein, Duncan Gallagher, James Patrick Jr Nelli, Jason Alger, Linda Llewelyn and Paul Horstmeier. View institutional ownership trends. How do I buy shares of Health Catalyst? Shares of HCAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:HCAT) was last updated on 4/17/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe “Perfect Storm” for GoldGold Safe ExchangeThe "Smart Money" Is Ready for May 1st Are You?Stansberry ResearchOptions trading has suddenly become more reliable.Eagle PublishingTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsYou won't believe what Citigroup just did to it's depositorsAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Health Catalyst, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.